INDV
Indivior Pharmaceuticals Stock Analysis
AI Rating
- Quality9/10
- Growth↑ 9/10
- Momentum↑ 9/10
INDV Growth
- Revenue Y/Y↓ -0.17%
- EPS Y/Y↑ 295.52%
- FCF Y/Y↑ 129.77%
INDV Profitability
- Gross margin ↑ 82.90%
- EPS margin↑ 14.10%
- ROIC↑ 84.10%
INDV Risk
- Debt / Equity↓ -1.7
- Debt / FCF↓ 0.0
- Interest coverage↑ 5.7
Indivior Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.